View ValuationDuta Pertiwi Nusantara 将来の成長Future 基準チェック /06現在、 Duta Pertiwi Nusantaraの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長-44.6%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 07PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 09, 2026PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 09, 2026. Location: jakarta IndonesiaReported Earnings • Nov 05Third quarter 2025 earnings released: EPS: Rp3.66 (vs Rp1.53 in 3Q 2024)Third quarter 2025 results: EPS: Rp3.66 (up from Rp1.53 in 3Q 2024). Revenue: Rp1.73b (down 93% from 3Q 2024). Net income: Rp1.21b (up 139% from 3Q 2024). Profit margin: 70% (up from 2.1% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.お知らせ • May 07PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 12, 2025PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 12, 2025.Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: Rp13.06 (vs Rp5.93 in 2Q 2023)Second quarter 2024 results: EPS: Rp13.06 (up from Rp5.93 in 2Q 2023). Revenue: Rp17.2b (down 24% from 2Q 2023). Net income: Rp4.32b (up 120% from 2Q 2023). Profit margin: 25% (up from 8.7% in 2Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.New Risk • Jun 06New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 22% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (Rp131.1b market cap, or US$8.00m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.お知らせ • May 16PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 20, 2024PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 20, 2024.Reported Earnings • May 05First quarter 2024 earnings released: EPS: Rp8.05 (vs Rp14.84 in 1Q 2023)First quarter 2024 results: EPS: Rp8.05 (down from Rp14.84 in 1Q 2023). Revenue: Rp17.8b (down 55% from 1Q 2023). Net income: Rp2.67b (down 46% from 1Q 2023). Profit margin: 15% (up from 12% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Dec 07New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: Rp155.0b (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (Rp155.0b market cap, or US$9.98m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Valuation Update With 7 Day Price Move • Oct 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to Rp520, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 11x in the Chemicals industry in Indonesia. Total returns to shareholders of 138% over the past three years.Upcoming Dividend • Jun 28Upcoming dividend of Rp15.00 per share at 3.7% yieldEligible shareholders must have bought the stock before 05 July 2023. Payment date: 21 July 2023. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 3.7%. Lower than top quartile of Indonesian dividend payers (5.6%). Higher than average of industry peers (1.2%).Reported Earnings • Mar 30Full year 2022 earnings released: EPS: Rp86.42 (vs Rp72.12 in FY 2021)Full year 2022 results: EPS: Rp86.42 (up from Rp72.12 in FY 2021). Revenue: Rp200.9b (up 37% from FY 2021). Net income: Rp28.6b (up 20% from FY 2021). Profit margin: 14% (down from 16% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.Reported Earnings • Apr 07Full year 2021 earnings released: EPS: Rp72.12 (vs Rp11.52 in FY 2020)Full year 2021 results: EPS: Rp72.12 (up from Rp11.52 in FY 2020). Revenue: Rp147.2b (up 52% from FY 2020). Net income: Rp23.9b (up Rp20.1b from FY 2020). Profit margin: 16% (up from 3.9% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Aug 13Investor sentiment improved over the past weekAfter last week's 25% share price gain to Rp376, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 25x in the Chemicals industry in Indonesia. Total returns to shareholders of 15% over the past three years.Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improved over the past weekAfter last week's 18% share price gain to Rp308, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total loss to shareholders of 21% over the past three years.Is New 90 Day High Low • Feb 20New 90-day high: Rp286The company is up 8.0% from its price of Rp266 on 20 November 2020. The Indonesian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.Is New 90 Day High Low • Jan 06New 90-day high: Rp278The company is up 22% from its price of Rp228 on 09 October 2020. The Indonesian market is up 21% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 25% over the same period.Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 16% share price gain to Rp268, the stock is trading at a trailing P/E ratio of 13.9x, up from the previous P/E ratio of 12x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total return to shareholders over the past three years is a loss of 16%.Is New 90 Day High Low • Oct 21New 90-day low: Rp216The company is down 21% from its price of Rp274 on 22 July 2020. The Indonesian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 6.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Duta Pertiwi Nusantara は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測IDX:DPNS - アナリストの将来予測と過去の財務データ ( )IDR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/202529,9028,315-16,397-15,941N/A6/30/202552,1077,608-4,800-4,224N/A3/31/202568,46714,0088,9599,580N/A12/31/202479,44614,31523,80124,428N/A9/30/202487,27011,61139,04439,711N/A6/30/202489,08817,28129,92930,306N/A3/31/202494,37914,92036,49636,831N/A12/31/2023116,20117,16825,67426,011N/A9/30/2023127,91016,33114,65814,850N/A6/30/2023164,60420,88520,11120,168N/A3/31/2023194,01227,46411,11511,171N/A12/31/2022200,91328,61619,35320,535N/A9/30/2022203,97030,417-8,427-3,530N/A6/30/2022185,21726,677-8,334-3,445N/A3/31/2022169,27026,480-6,806-1,416N/A12/31/2021147,21023,881-4,432404N/A9/30/2021129,29918,62525,69826,895N/A6/30/2021108,15614,52523,27124,501N/A3/31/202195,5904,75912,74213,629N/A12/31/202096,6453,81511,34911,666N/A9/30/202099,2296,38916,66717,260N/A6/30/2020102,6153,3874,6295,119N/A3/31/2020106,5284,8127,5068,511N/A12/31/2019118,9175,1638542,121N/A9/30/2019125,8743,815-14,328-12,050N/A6/30/2019142,5438,150N/A-2,945N/A3/31/2019149,01910,601N/A-9,344N/A12/31/2018143,38210,417N/A-12,882N/A9/30/2018138,48211,625N/A-5,468N/A6/30/2018125,5719,957N/A-6,594N/A3/31/2018117,3119,174N/A-2,063N/A12/31/2017111,2957,057N/A-3,994N/A9/30/2017105,1897,445N/A-9,777N/A6/30/2017104,7627,409N/A-6,333N/A3/31/2017107,3498,133N/A2,091N/A12/31/2016115,94111,286N/A14,128N/A9/30/2016117,3356,656N/A14,646N/A6/30/2016116,3367,840N/A15,559N/A3/31/2016116,1807,588N/A14,360N/A12/31/2015118,47510,960N/A5,106N/A9/30/2015126,68715,778N/A19,901N/A6/30/2015129,17215,729N/A15,077N/A3/31/2015140,22518,729N/A17,642N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: DPNSの予測収益成長が 貯蓄率 ( 6.7% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: DPNSの収益がID市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: DPNSの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: DPNSの収益がID市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: DPNSの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: DPNSの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/01/27 00:46終値2025/10/30 00:00収益2025/09/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋PT Duta Pertiwi Nusantara Tbk 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 07PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 09, 2026PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 09, 2026. Location: jakarta Indonesia
Reported Earnings • Nov 05Third quarter 2025 earnings released: EPS: Rp3.66 (vs Rp1.53 in 3Q 2024)Third quarter 2025 results: EPS: Rp3.66 (up from Rp1.53 in 3Q 2024). Revenue: Rp1.73b (down 93% from 3Q 2024). Net income: Rp1.21b (up 139% from 3Q 2024). Profit margin: 70% (up from 2.1% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
お知らせ • May 07PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 12, 2025PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 12, 2025.
Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: Rp13.06 (vs Rp5.93 in 2Q 2023)Second quarter 2024 results: EPS: Rp13.06 (up from Rp5.93 in 2Q 2023). Revenue: Rp17.2b (down 24% from 2Q 2023). Net income: Rp4.32b (up 120% from 2Q 2023). Profit margin: 25% (up from 8.7% in 2Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
New Risk • Jun 06New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 22% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (Rp131.1b market cap, or US$8.00m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
お知らせ • May 16PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 20, 2024PT Duta Pertiwi Nusantara Tbk, Annual General Meeting, Jun 20, 2024.
Reported Earnings • May 05First quarter 2024 earnings released: EPS: Rp8.05 (vs Rp14.84 in 1Q 2023)First quarter 2024 results: EPS: Rp8.05 (down from Rp14.84 in 1Q 2023). Revenue: Rp17.8b (down 55% from 1Q 2023). Net income: Rp2.67b (down 46% from 1Q 2023). Profit margin: 15% (up from 12% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Dec 07New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: Rp155.0b (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (Rp155.0b market cap, or US$9.98m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Valuation Update With 7 Day Price Move • Oct 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to Rp520, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 11x in the Chemicals industry in Indonesia. Total returns to shareholders of 138% over the past three years.
Upcoming Dividend • Jun 28Upcoming dividend of Rp15.00 per share at 3.7% yieldEligible shareholders must have bought the stock before 05 July 2023. Payment date: 21 July 2023. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 3.7%. Lower than top quartile of Indonesian dividend payers (5.6%). Higher than average of industry peers (1.2%).
Reported Earnings • Mar 30Full year 2022 earnings released: EPS: Rp86.42 (vs Rp72.12 in FY 2021)Full year 2022 results: EPS: Rp86.42 (up from Rp72.12 in FY 2021). Revenue: Rp200.9b (up 37% from FY 2021). Net income: Rp28.6b (up 20% from FY 2021). Profit margin: 14% (down from 16% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Apr 07Full year 2021 earnings released: EPS: Rp72.12 (vs Rp11.52 in FY 2020)Full year 2021 results: EPS: Rp72.12 (up from Rp11.52 in FY 2020). Revenue: Rp147.2b (up 52% from FY 2020). Net income: Rp23.9b (up Rp20.1b from FY 2020). Profit margin: 16% (up from 3.9% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Aug 13Investor sentiment improved over the past weekAfter last week's 25% share price gain to Rp376, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 25x in the Chemicals industry in Indonesia. Total returns to shareholders of 15% over the past three years.
Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improved over the past weekAfter last week's 18% share price gain to Rp308, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total loss to shareholders of 21% over the past three years.
Is New 90 Day High Low • Feb 20New 90-day high: Rp286The company is up 8.0% from its price of Rp266 on 20 November 2020. The Indonesian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.
Is New 90 Day High Low • Jan 06New 90-day high: Rp278The company is up 22% from its price of Rp228 on 09 October 2020. The Indonesian market is up 21% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 25% over the same period.
Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 16% share price gain to Rp268, the stock is trading at a trailing P/E ratio of 13.9x, up from the previous P/E ratio of 12x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total return to shareholders over the past three years is a loss of 16%.
Is New 90 Day High Low • Oct 21New 90-day low: Rp216The company is down 21% from its price of Rp274 on 22 July 2020. The Indonesian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 6.0% over the same period.